A Randomized, Evaluator-Blinded, Phase 3 Study to Compare the Safety and Efficacy of PTK 0796 With Linezolid in the Treatment of Adults With Complicated Skin and Skin Structure Infection.
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 13 Apr 2016
At a glance
- Drugs Omadacycline (Primary) ; Omadacycline (Primary) ; Linezolid; Linezolid; Moxifloxacin; Moxifloxacin
- Indications Gram-negative infections; Gram-positive infections; Skin and soft tissue infections
- Focus Registrational; Therapeutic Use
- Sponsors Paratek Pharmaceuticals
- 03 May 2012 Status changed from not yet recruiting to withdrawn prior to recruitment.
- 14 Apr 2009 New trial record